Main > ONCOLOGY (**) > Breast Cancer>HER2+>Adjuvant *** > USA. G. PertuzuMAb+TrastuzuMAb+ SC > (*) EU CE Mark Date: 2020. 12.23.




(*) EU CE Mark Date: 2020. 12.23.'s products
This section has no products